Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986331 in Healthy Participants
Clinical trial NCT04444050 · COMPLETED
Trial details
- NCT number
- NCT04444050
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2021-05-19
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.